🏥 Max Healthcare Strengthens Growth Visibility with Aggressive Expansion & Strong FY26 Performance

Max Healthcare Institute Limited continues to showcase strong operational momentum backed by premium healthcare demand, metro-focused expansion, and improving profitability. ### FY26 Highlights 🔹 Net Revenue rose to **₹10,065 Cr** (+16% YoY) 🔹 Operating EBITDA stood at **₹2,638 Cr** 🔹 PAT jumped to **₹1,631 Cr** (+22% YoY) 🔹 FY26 Occupancy remained healthy at **~76%** 🔹 ROCE stood at **~23%** ### Q4FY26 Snapshot ✅ Revenue at **₹2,541 Cr** ✅ EBITDA at **₹682 Cr** ✅ PAT at **₹387 Cr** ✅ EBITDA Margin improved to **26.8%** ### Key Growth Drivers 📌 Expansion pipeline of **8,400+ beds** over coming years 📌 Focus on high-growth metro markets 📌 Strong traction in: * Medical tourism * Diagnostics (Max Lab) * Homecare (Max@Home) * Digital healthcare ecosystem ### Strategic Focus The company remains focused on: ✔️ Asset-light expansion ✔️ Brownfield capacity additions ✔️ AI & digital healthcare initiatives ✔️ Value-accretive acquisitions ✔️ Maintaining industry-leading ROCE With a strong balance sheet, rising healthcare demand, and an aggressive expansion roadmap, Max Healthcare continues to strengthen its position among India’s leading premium healthcare providers. #MaxHealthcare #Healthcare #Hospitals #Q4FY26 #HealthcareSector #IndianStockMarket #StockMarketIndia #Investing #HealthcareGrowth #MarketUpdate #AFSTradingEdge ⚠️ Disclaimer: This post is for educational and informational purposes only and should not be considered investment advice. $MAXHEALTH